The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has once again snubbed Translarna ...

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

The acquisition will add a late-stage drug candidate with blockbuster potential to Lundbeck’s neuroscience pipeline.

At the forefront of precision dosing, Sharmeen leads DoseMe's efforts to transform personalized medicine from lab research to ...

As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...

In today's regulatory landscape, ensuring data integrity is crucial for compliance and process visibility. How can ...

Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...

Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...